# CANDEL THERAPEUTICS INC (CADL)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CADL/

- Reporting holders: 2
- Reported value: $23.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $20.9K | 2,003 | 0.0% | 9 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.5K | 237 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $23.4K |
| Q2 2026 | 141 | $568.3M |
| Q1 2026 | 115 | $216.0M |
| Q4 2025 | 84 | $136.2M |
| Q3 2025 | 84 | $119.4M |
| Q2 2025 | 82 | $122.4M |
| Q1 2025 | 85 | $126.8M |
| Q4 2024 | 72 | $170.9M |
| Q3 2024 | 52 | $48.2M |
| Q2 2024 | 48 | $38.2M |
| Q1 2024 | 18 | $2.9M |
| Q4 2023 | 20 | $3.1M |